N. Arun, A. Dev, and V. K. Singh, “A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir with Ribaravin in the Treatment of Chronic Hepatitis C Patients with Cirrhosis, Genotype 1 and 3.”, AJMR, vol. 7, no. 4, pp. ME25-ME28, Jan. 2019.